Retour
32
26
Fourchette du Jour
27,00 €
27,00 €
Fourchette 52 Semaines
20,03 €
27,00 €
Volume
2 500
Moyenne 50J / 200J
26,41 €
/
24,68 €
Clôture Précédente
27,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 21,7 | 0,4 |
| P/B | 3,6 | 2,9 |
| ROE % | 17,3 | 3,7 |
| Net Margin % | 9,6 | 3,9 |
| Rev Growth 5Y % | 13,5 | 10,0 |
| D/E | 0,9 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
2,41 €
2,32 € – 2,49 €
|
1,5 B | 1 |
| FY2028 |
1,85 €
1,78 € – 1,91 €
|
1,3 B | 1 |
| FY2027 |
1,60 €
1,54 € – 1,66 €
|
1,2 B | 1 |
Points Clés
Revenue grew 13,49% annually over 5 years — strong growth
ROE of 17,29% — decent returns on equity
Generating 112,98M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,33%
Cash machine — converts 124,18% of earnings into free cash flow
Capital efficient — spends only 1,60% of revenue on capex
Croissance
Revenue Growth (5Y)
13,49%
Revenue (1Y)9,16%
Earnings (1Y)12,95%
FCF Growth (3Y)14,51%
Qualité
Return on Equity
17,29%
ROIC10,30%
Net Margin9,56%
Op. Margin15,36%
Sécurité
Debt / Equity
0,93
Current Ratio2,11
Interest Coverage4,47
Valorisation
P/E Ratio
21,73
P/B Ratio3,59
EV/EBITDA15,77
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,16% | Revenue Growth (3Y) | 11,69% |
| Earnings Growth (1Y) | 12,95% | Earnings Growth (3Y) | 13,57% |
| Revenue Growth (5Y) | 13,49% | Earnings Growth (5Y) | 10,51% |
| Profitability | |||
| Revenue (TTM) | 951,81M | Net Income (TTM) | 90,99M |
| ROE | 17,29% | ROA | 7,32% |
| Gross Margin | 15,25% | Operating Margin | 15,36% |
| Net Margin | 9,56% | Free Cash Flow (TTM) | 112,98M |
| ROIC | 10,30% | FCF Growth (3Y) | 14,51% |
| Safety | |||
| Debt / Equity | 0,93 | Current Ratio | 2,11 |
| Interest Coverage | 4,47 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 21,73 | P/B Ratio | 3,59 |
| P/S Ratio | 2,08 | PEG Ratio | 1,26 |
| EV/EBITDA | 15,77 | Dividend Yield | 0,02% |
| Market Cap | 1,98B | Enterprise Value | 2,31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 951,81M | 871,96M | 762,99M | 683,88M | 573,81M |
| Net Income | 90,99M | 80,55M | 70,55M | 69,61M | 61,00M |
| EPS (Diluted) | 1,24 | 1,10 | 0,97 | 0,96 | 0,84 |
| Gross Profit | 145,13M | 395,68M | 332,61M | 286,17M | 247,50M |
| Operating Income | 146,16M | 130,70M | 108,63M | 97,91M | 87,44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,24B | 1,08B | 1,01B | 971,01M | 800,42M |
| Total Liabilities | 686,62M | 578,16M | 539,33M | 562,38M | 474,96M |
| Shareholders' Equity | 551,40M | 501,35M | 463,75M | 402,66M | 320,11M |
| Total Debt | 512,59M | 385,70M | 366,74M | 399,38M | 335,59M |
| Cash & Equivalents | 184,83M | 115,04M | 133,01M | 125,34M | 70,65M |
| Current Assets | 462,67M | 362,56M | 335,90M | 318,01M | 233,71M |
| Current Liabilities | 218,90M | 194,71M | 175,26M | 171,01M | 145,06M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#782 of 1024
Custom
Balanced Risk
#142 of 148
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Balanced Risk
Mar 24, 2026